Previous 10 | Next 10 |
SOD1 -ALS is a devastating, uniformly fatal, and ultra-rare genetic form of ALS affecting less than 1,000 people in Europe 1 With QALSODY, Biogen has advanced the role of neurofilament in the development of new medicines for ALS, with the potential to accelerate further discovery in the...
2024-02-21 14:33:22 ET More on Invesco QQQ ETF QQQ: Why It Could Be The Best Single Investment For The Next 20+ Years SPDR S&P 500 ETF And Invesco QQQ Trust: Almost All Investors Are Crowded Into The Same Side Of The Boat Mean Reversion Pair Trade: Long IWM, Shor...
A look at the top 10 most actives in the United States PROSHARES TRUST (SQQQ) rose 2.8% to $11.65 on volume of 139,655,455 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) rose 2.1% to $4.39 on volume of 127,826,661 shares SoundHound AI Inc. (SOUN) rose 1.6% to $3.82 on volume of...
2024-02-17 03:38:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
A look at the top 10 most actives in the United States PROSHARES TRUST (SQQQ) rose 2.3% to $11.595 on volume of 119,263,238 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) rose 0.8% to $4.3323 on volume of 111,414,526 shares SoundHound AI Inc. (SOUN) rose 0.0% to $3.7601 on volu...
A look at the top 10 most actives in the United States Direxion Daily Semiconductor Bear 3X Shares (SOXS) fell 6.3% to $4.3 on volume of 124,140,302 shares Treasure Global Inc. (TGL) rose 60.4% to $0.1588 on volume of 122,843,335 shares PROSHARES TRUST (SQQQ) fell 3.3% to $11.41 on volume...
A look at the top 10 most actives in the United States Direxion Daily Semiconductor Bear 3X Shares (SOXS) fell 5.9% to $4.3207 on volume of 110,964,333 shares PROSHARES TRUST (SQQQ) fell 2.3% to $11.534 on volume of 98,370,244 shares Lyft Inc. (LYFT) rose 34.3% to $16.29 on volume of 91,0...
2024-02-14 10:33:07 ET Read the full article on Seeking Alpha For further details see: DOJ issues subpoena for info on Biogen's foreign operations
2024-02-14 09:50:29 ET More on Biogen Biogen's Q4 Earnings Disappoint Amidst Strategic Challenges (Rating Downgrade) Biogen Inc. (BIIB) Q4 2023 Earnings Call Transcript Biogen Inc. 2023 Q4 - Results - Earnings Call Presentation Biogen slips as outlook disappo...
2024-02-14 02:55:38 ET Summary Q4 earnings underwhelmed, with misses on EPS and revenue; Leqembi and Zurzuvae's performances were particularly disappointing. Biogen's significant investments in Alzheimer's treatments, especially Leqembi, have yet to yield substantial returns. ...
News, Short Squeeze, Breakout and More Instantly...
Thursday, Ionis Pharmaceuticals Inc (NASDAQ:IONS) and Biogen Inc (NASDAQ:BIIB) decided to terminate the development of BII...
Development of BIIB105, an investigational antisense oligonucleotide for amyotrophic lateral sclerosis (ALS), will be discontinued based on data from the Phase 1/2 ALSpire study Biogen and Ionis continue their long-standing commitment to developing therapies for ALS given the devastating impa...
Eisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI® (lecanemab-irmb) for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer's Disease Under the Fast Track Status PR Newswire TOKYO and CAMBRIDGE, Mass. , May 14, 2024...